Deerfield Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Deerfield Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,750,000	Closed	-$17.4M	–	115
2022 Q4	$17.4M	Hold	1,750,000	–	–	0.36%	62
2022 Q3	$9.64M	Hold	1,750,000	–	–	0.19%	87
2022 Q2	$6.39M	Hold	1,750,000	–	–	0.13%	87
2022 Q1	$10.6M	Hold	1,750,000	–	–	0.24%	69
2021 Q4	$14.8M	Buy	+1,750,000	New	+$15.3M	0.31%	71

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Deerfield Management's APEN Position: Q1 2023 in Review

Deerfield Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 1,750,000 shares — an estimated $17.4M sold.

Deerfield Management first reported a position in APEN in Q4 2021 and held it in 5 quarters. The position peaked at $17.4M in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

Deerfield Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
Deerfield Management sold 1,750,000 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $17.4M.
Deerfield Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 5 quarters.
Deerfield Management's Apollo Endosurgery, Inc. position peaked at $17.4M in Q4 2022.
89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Deerfield Management's 13F filing for Q1 2023, filed 15 May 2023.